GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.

Treatments such as endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT), are becoming more accessible to patients and leading to paradigm shifts in their outcomes.

London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies ...

GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment optionsPhase II data show ...

LEE HARRIS: It would have been the elephant in the room if we didn't play it. If you think of a Saucers show as a book telling the story of Pink Floyd's early years and how they became what they did ...

CS 1.1 cheat codes or Half Life codes are not always used to cheat people around. Many Counter Strike 1.1 commands can help gamers because of their playing habits. CS 1.1 cheat codes can also be used ...

OKLAHOMA CITY — The Minnesota Timberwolves were outscored 70-40 in the final two quarters as the Oklahoma City Thunder rallied in the second half to win 114-88 and take the early advantage in ...

Launched almost half a century ago, Voyager 1 and its sister probe Voyager 2 have a special place in the heart of NASA, which is determined to keep the robotic pair functioning so long as there's ...

Katie Falzone; Senior Vice President, Finance; Invivyd Inc. Marc Elia; Independent Chairman of the Board; Invivyd Inc. Tim Lee; Chief Commercial Officer; Invivyd Inc ...

Advancements in fusion energy modeling, including a new guiding center model, enhance plasma simulations and address key challenges for practical fusion energy.